ESC Report 2013 – Alogliptin treatment shows no increase cardiovascular risk in Acute Coronary Syndrome
by Bruce Sylvester – Alogliptin treatment of patients with type 2 diabetes and with high cardiovascular risk due to recent acute coronary syndromes has led to similar rates… read more.